(Q35106461)

6 August 2017

1 reference

title

Pathophysiology of heart failure: identifying targets for pharmacotherapy (English)

1 reference

6 August 2017

0 references

1 reference

Arnold M. Katz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693727

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693727

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0025712502001888?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00188-8

https://api.elsevier.com/content/article/PII:S0025712502001888?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00188-8

Medical Clinics of North America

23 December 2023

published in

1 reference

6 August 2017

volume

87

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

303-316

1 reference

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle--Part I.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

The Neurohumoral Axis in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Evolution and the cardiac patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

“Tonic” and “phasic” mechanisms in the regulation of myocardial contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Wall stress and patterns of hypertrophy in the human left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Wall stress in the normal and hypertrophied human left ventricle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

LEFT VENTRICULAR TENSION AND STRESS IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Myofibrillar adenosine triphosphatase activity in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Signal transduction. Team blue sees red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Homogeneity out of heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Integrin signaling: specificity and control of cell survival and cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Integrins, adhesion, and cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

The Regulation of Growth and Intracellular Signaling by Integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Cadherin-catenin complex: Protein interactions and their implications for cadherin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Molecular and functional analysis of cadherin-based adherens junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Regulation of cardiomyocyte mechanotransduction by the cardiac cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Stress pathways and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Mechanisms and models in heart failure: A combinatorial approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900188-8

On the mechanism of compensatory hyperfunction and insufficiency of the heart

7 January 2021

series ordinal

16

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00188-8

Integrin-dependent signal transduction

23 December 2023

series ordinal

25

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00188-8

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference